Smooth transition to the new MDR/IVDR

MDR (Medical Device Regulation)

is the new regulation of the European Union in the field of medical device. 

 

* The IVDR (In Vitro Diagnostic Regulation 2017 / 746) regulations will be applied on 26 May 2022.

160461991_s.jpg

What is the significant changes between the existing directive and the new regulation

Today there are three different directives that regulate medical devices in Europe, which has led to certain countries introducing additional requirements for the placing of Medical Devices in their territories (such as national registrations). The regulation is, by definition, applied equally across the European Union, and no longer allows for individual interpretation in each country.

The new regulation has come about in order to strengthen the weak links and resolve the issues that have been identified since the application of the Directives in the late 1990s’, mainly in three areas: new technologies (such as medical- aesthetics products, software, etc.), traceability of events and products and public transparency.

What are the new regulation's Principles?

  • High-risk products are required to face much stricter quality control and audit.

  • A new system for approving and supervising Notified Bodies.

  • Clear procedures for the certification process (frequency of each test, audit plan, clear content).

  • Inclusion of products without a medical purpose.

  • New classification rules

  • Transparency of information to the general public.

  • Evaluation of up-to-date clinical information (for all types of a medical device - also Class I).

  • NEW obligations on importers and distributors located in Europe

  • Designation of the person responsible for the regulation in the country of manufacture (PRRC).

  • Collaborations between health authorities.

What should you do in order to be prepared for the NEW requirements?

STEP 1 - Classification
To comply with the new requirements, manufacturers must first establish the classification of their devices, according to the new classification rules, and act accordingly. It is important to note that there are products that are currently at a low-risk level (Class I) but might become a medium-risk level (IIa) or high-risk level (Class III) under the new regulation. For example, software or surgical gloves that are currently classified today as Class I, but under the new regulation, they will be classified as Class IIa or III (!).

 
STEP 2 - Identification
manufacturers must figure out what the new regulation means in terms of product approval and what is relevant to your specific device. It is advisable to run a gap analysis in order to update the technical portfolio, quality system, evaluation, and clinical plan, and even address cases where there is an overlap between the new regulation MDR and other regulations, such as the GDPR.
 
STEP 3 – Technical Documentation
Once we have mapped the requirements, understood the classification, coordinated expectations with the notified body or an authorized representative in the EU – we can start modifying the technical documentation (Technical File) and quality management system (although the manufacturer is required to present a quality management system under the new regulation, the recommendation is to apply ISO 13485:2016 version, mostly since it’s the acceptable standard for quality system management, but also because it is "best" evidence to show compliance with the quality management system requirements.

STEP 4 – Notified Body & Authorized Representative
Once all these have been compiled and reviewed, the manufacturer must contact a Notified Body and a European Authorized Representative in order to certify the medical device under the MDR and complete the EUDAMED registration.
 
STEP 5 –  CE Marking & EUDAMED
One of the main objectives of the MDR was to offer transparency to the general public. To this end, a European database EUDAMED (European Database of Medical Device) has been set up, into which data will be entered on a regular basis. This will include clinical data, clinical investigations, incidents, and reports. In addition, the manufacturer is required to submit to the authorities an annual report detailing the manufacturer's activity and the medical Device PSUR (= Periodic safety update reports), in order to increase transparency.
 
There is no doubt that the transition between the existing directives and the new regulation may prove revolutionary, although there are undoubtedly still some unanswered questions. The EU is determined to meet the set deadlines and bring the new regulation into effect in May 2021.

How can we help?

We offer a variety of services designed to accompany and support medical device manufacturers in Israel throughout all the steps listed above, to enable you  a smooth and convenient transition that will meet the requirements of the new regulations under European Medical Device Regulation (IVDR / MDR).

 

In addition, we will be happy to provide you with a comprehensive professional assistant on other quality and regulatory issues related to medical device services such as: consultant for the PRRC in your organization and  outsourced PRRC , all for the benefit of the organization's compliance with the new regulatory guidelines.

We Provide close and available guidance to any subject in the shortest time as possible.

We provide full transparency to all interested parties and invite you to visit us at any time.

We have more then 16  years of business experience with

a professional and reliable reputation in the field.

The company's services are performed by a skilled team, in order to provide fast and efficient service to all our customers.

We will be happy to assist with any question and request